{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:36:09Z","timestamp":1769160969763,"version":"3.49.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Selective Decontamination of the Digestive tract (SDD) aims to prevent nosocomial infections, by eradication of potentially pathogenic micro-organisms from the digestive tract.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To estimate the rate of and the time to eradication of resistant vs. susceptible facultative aerobic gram-negative bacteria (AGNB) in patients treated with SDD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This observational and retrospective study included patients admitted to the ICU between January 2001 and August 2017. Patients were included when treated with SDD (tobramycin, polymyxin B, and amphotericin B) and colonized in the upper or lower gastro-intestinal (GI) tract with at least one AGNB present on admission. Decontamination was determined after the first negative set of cultures (rectal and throat). An additional analysis was performed of two consecutive negative cultures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 281 susceptible AGNB in the throat and 1,087 in the rectum on admission, 97.9 and 93.7%, respectively, of these microorganisms were successfully eradicated. In the upper GI-tract no differences in eradication rates were found between susceptible and resistant microorganisms. However, the median duration until eradication was significantly longer for aminoglycosides resistant vs. susceptible microorganisms (5 vs. 4 days, <jats:italic>p<\/jats:italic> &amp;lt; 0.01). In the lower GI-tract, differences in eradication rates between susceptible and resistant microorganisms were found for cephalosporins (90.0 vs. 95.6%), aminoglycosides (84.4 vs. 95.5%) and ciprofloxacin (90.0 vs. 95.2%). Differences in median duration until eradication between susceptible and resistant microorganisms were found for aminoglycosides and ciprofloxacin (both 5 days vs. 6 days, <jats:italic>p<\/jats:italic> = 0.001). Decontamination defined as two negative cultures was achieved in a lower rate (77\u201398% for the upper GI tract and 64\u201377% for the lower GI tract) and a median of 1 day later.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The vast majority of both susceptible and resistant microorganisms are effectively eradicated from the upper and lower GI tract. In the lower GI tract decontamination rates of susceptible microorganisms are significantly higher and achieved in a shorter time period compared to resistant strains.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2021.779805","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T06:38:13Z","timestamp":1643870293000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Sophie H.","family":"Buitinck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogier","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob J.","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nardo J. M.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H. J.","family":"van der Voort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/mdr.2010.0060","article-title":"Is selective digestive decontamination useful in controlling aerobic gram-negative bacilli producing extended spectrum beta-lactamases?","volume":"17","author":"Abecasis","year":"2011","journal-title":"Microb. Drug Resist."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2480-z","article-title":"The ecological effects of selective decontamination of the digestive tract (SDD) on antimicrobial resistance: a 21-year longitudinal single-centre study.","volume":"23","author":"Buitinck","year":"2019","journal-title":"Crit. Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/cc13096","article-title":"Clinical stakeholders\u2019 opinions on the use of selective decontamination of the digestive tract in critically ill patients in intensive care units: an international Delphi study.","volume":"17","author":"Cuthbertson","year":"2013","journal-title":"Crit. Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S1473-3099(12)70322-5","article-title":"SuDDICU canadian study group. effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.","volume":"13","author":"Daneman","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B5","year":"2021","journal-title":"EUCAST Breakpoint Table Version 1.0."},{"key":"B6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B Sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.","volume":"33","author":"Evans","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"B7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jac\/dkt416","article-title":"Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands.","volume":"69","author":"Houben","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jinf.2019.02.007","article-title":"Use of enteral amikacin to eliminate carriership with multidrug resistant Enterobacteriaceae.","volume":"78","author":"Nahar","year":"2019","journal-title":"J. Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1007\/s00134-011-2307-0","article-title":"Long-term use of selective decontamination of the digestive tract does not increase antibiotic resistance: a 5-year prospective cohort study.","volume":"37","author":"Ochoa-Ardila","year":"2011","journal-title":"Intensive Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/jac\/dks187","article-title":"Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units.","volume":"67","author":"Oostdijk","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmi.2017.08.019","article-title":"Selective digestive and oropharyngeal decontamination in medical and surgical ICU patients: individual patient data meta-analysis.","volume":"24","author":"Plantinga","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/sim.4780071106","article-title":"Remission duration: an example of interval-censored observations.","volume":"7","author":"Rucker","year":"1988","journal-title":"Stat. Med."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2057-2","article-title":"Long-term use of selective digestive decontamination in an ICU highly endemic for bacterial resistance.","volume":"22","author":"Sanchez-Ramirez","year":"2018","journal-title":"Crit. Care"},{"key":"B14","first-page":"21","article-title":"Selective decontamination of the digestive tract: an update of the evidence.","volume":"4","author":"Silvestri","year":"2012","journal-title":"HSR Proc. Intensive Care Cardiovasc. Anesth."},{"key":"B15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jhin.2006.10.014","article-title":"Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials.","volume":"65","author":"Silvestri","year":"2007","journal-title":"J. Hosp. Infect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S1473-3099(11)70035-4","article-title":"Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study.","volume":"11","author":"Smet","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jac\/19.4.513","article-title":"The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit.","volume":"19","author":"Stoutenbeek","year":"1987","journal-title":"J. Antimicrob. Chemother."},{"key":"B18","first-page":"87","article-title":"Ten tips and tricks for successful digestive tract decontamination.","volume":"27","author":"Van Der Voort","year":"2019","journal-title":"Netherlands J. Crit. Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00134-003-1722-2","article-title":"All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.","volume":"29","author":"van Saene","year":"2003","journal-title":"Intensive Care Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/0310057X1003800215","article-title":"The role of admission surveillance cultures in patients requiring prolonged mechanical ventilation in the intensive care unit.","volume":"38","author":"Viviani","year":"2010","journal-title":"Anaesth. Intensive Care"},{"key":"B21","author":"Vollaard","year":"1991","journal-title":"The Concept of Colonization Resistance, A Study of the Influence of Antimicrobial Agents on Aerobic Flora of the Bowel."},{"key":"B22","author":"Wayne","year":"2010","journal-title":"Performance Standards for Antimicrobial Susceptibility Testing. Twentieth Informational Supplement."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0838-4","article-title":"Colistin and tobramycin resistance during long- term use of selective decontamination strategies in the intensive care unit: a post hoc analysis.","volume":"19","author":"Wittekamp","year":"2015","journal-title":"Crit. Care"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.779805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T06:38:21Z","timestamp":1643870301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.779805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":23,"alternative-id":["10.3389\/fmicb.2021.779805"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.779805","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"article-number":"779805"}}